Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection

Canadian Journal of Gastroenterology and Hepatology

Volumn 28, Issue 6, 2014, Pages 319-324

  Zipursky, Jonathan S ^a   Sidorsky, Tivon I ^b   Freedman, Carolyn A ^c   Sidorsky, Misha N ^d   Kirkland, Kathryn B ^e  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d DARTMOUTH COLLEGE   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Clostridium difficile infection; Fecal microbiota transplantation; Fecal transplant; Physician attitudes; Shared decision making

Indexed keywords

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEMALE; HEALTH BELIEF; HEALTH CARE SURVEY; HUMAN; JOB EXPERIENCE; MALE; MEDICAL SPECIALIST; MIDDLE AGED; NONHUMAN; PHYSICIAN ATTITUDE; PREDICTIVE VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSPLANTATION; TREATMENT PLANNING; YOUNG ADULT; BIOLOGICAL THERAPY; CLINICAL PRACTICE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEW HAMPSHIRE; PATIENT ATTITUDE; PEPTOCLOSTRIDIUM DIFFICILE; STATISTICS AND NUMERICAL DATA; TEXAS;

ADULT; AGED; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW HAMPSHIRE; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE PATTERNS, PHYSICIANS'; TEXAS;

EID: 84902653790     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2014/403828     Document Type: Article

References (27)

1. Kachrimanidou M, Malisiovas N. Clostridium difficile infection: A comprehensive review. Crit. Rev. Microbiol 2011;37:178-87.
2. Bartlett J. Narrative Review: The new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006;145:758-64. (Pubitemid 351650356)
3. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-15.
4. Kelly C, LaMont J. Clostridium difficile - more difficult than ever. N Engl J Med 2008;359:1932-40.
5. Gravel D, Miller M, Simor A, et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009;48:568-76.
6. Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile -associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005;173:1037-42.
7. United Kingdom national statistics. Newport, United Kingdom: Office for National Statistics, UK Statistics Authority. 〈www.statistics.gov.uk〉 (Accessed September 26, 2012).
8. Pepin J, Alary M-E, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-7. (Pubitemid 40720808)
9. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
10. Nood E Van, Speelman P, Kuijper E, et al. Struggling with recurrent Clostridium difficile infections: Is donor faeces the solution? Euro Surveill 2009;359:1-6.
11. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009;15:285-9.
12. Huebner ES, Surawicz CM. Treatment of recurrent Clostridium difficile diarrhea. Gastroenterol Hepatol 2006;2:203-8. (Pubitemid 46050747)
13. Pépin J, Routhier S, Gagnon S, et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 2006;42:758-64. (Pubitemid 43363928)
14. Borody TJ, Warren EF, Leis SM, et al. Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol 2004;38:475-83. (Pubitemid 38808419)
15. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002.
16. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-15.
17. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we? Inflamm Bowel Dis 2012;18:676-84.
18. Borody TJ, Campbell J. Fecal microbiota transplantation: Current status and future directions. Expert Rev Gastroenterol Hepatol 2011;5:653-5.
19. Zipursky JS, Sidorsky TI, Freedman CA, et al. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012;55:1-7.
20. Clostridium difficile Infection. Centers Dis Control Prev Heal Infect 〈www.cdc.gov/hai/organisms/cdiff/cdiff-infect.html〉 (Accessed September 26, 2012).
21. Kelly CP, LaMont J. Clostridium difficile in adults: Treatment. UpToDate. 〈www.uptodate.com〉 (Accessed September 26, 2012).
22. Kelly CP. Fecal microbiota transplantation - an old therapy comes of age. N Engl J Med 2013;368:4745.
23. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011;9:1044-9.
24. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol 2010;8:471-3.
25. Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: "RePOOPulating" the gut. Microbiome 2013;1:3.
26. Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies. 2013. 〈GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379. htm〉 (Accessed June 26, 2013).
27. Kelly CR, Brandt LJ. Fecal Transplant for Relapsing C. Difficile Infection. ClinicalTrials.gov. 〈www.clinicaltrials.gov/ct2/show/ NCT01703494?term=fecal+transplant+brandt&rank=1〉 (Accessed June 26, 2013).